SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Glaukos Announces Third-Quarter 2026 Financial Results

Glaukos reported financial results for the quarter ended September 30, 2026.

GKOS
SquawkNews Desk

Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial results for the third quarter ended September 30, 2026. Key highlights include:“O…

Related stories

India's Nifty Bank futures fall 0.17% pre-open M impact | EQUITY | Oct 30, 2026, 03:40 AM UTC Trent shares rise 5.5% in pre-open trade after quarterly profit rise M impact | EQUITY | Oct 30, 2026, 03:40 AM UTC India's Nifty 50 futures fall 0.16% in pre-open trade M impact | EQUITY | Oct 30, 2026, 03:39 AM UTC H2O America Prices Equity Unit Offering H2O America announced pricing of an offering of equity units. M impact | EQUITY | Oct 30, 2026, 03:37 AM UTC Two Point Zero Group Reports Quarterly Revenue of AED 11.84 Billion M impact | EQUITY | Oct 30, 2026, 03:35 AM UTC Two Point Zero Group Reports Quarterly Profit of AED 1.51 Billion M impact | EQUITY | Oct 30, 2026, 03:34 AM UTC